April 2016

Editor's Page
Value in Health Care: In the Eye of the Beholder
Winston Wong, PharmD, Editor-in-Chief

J Clin Pathways. 2016;2(3):5.

Departments

Editor's Page
Value in Health Care: In the Eye of the Beholder
Winston Wong, PharmD, Editor-in-Chief

J Clin Pathways. 2016;2(3):5.

Research in Review
Pathways for Urologic Surgery Potentially Beneficial, Though More Research is Needed
JCP Editors

J Clin Pathways. 2016;2(3):8-11.

Interview
Devising Pathways Strategies That Maintain the Principles of Personalized Medicine
JCP Editors

J Clin Pathways. 2016;2(3):17-20.

Conference Coverage
Association of Community Cancer Centers Annual Meeting: CANCERSCAPE 2016
JCP Editors

J Clin Pathways. 2016;2(3):13-15.

Research in Review
Evidence-Based Training to Improve Physician Responses to Adverse Events
JCP Editors

J Clin Pathways. 2016;2(3):8-11.

Research in Review
Human Epidermal Growth Factor Receptor-2 a Strong Indicator of Breast Cancer Prognosis
JCP Editors

J Clin Pathways. 2016;2(3):8-11.

Columns

Pharma Insights
When Medication Price Deflates Perception of Therapeutic Effect
Larry Blandford, PharmD—Column Editor; Stephen C Carter

J Clin Pathways. 2016;2(3):25-26.

Clinical Pathways GPS
Adding Patient Navigation to the Clinical Pathway for Alzheimer Disease
Richard G Stefanacci, DO, MGH, MBA, AGSF, CMD—Column Editor; Harold Freeman, MD; Ruth Gay; Mary Michael; David Digby

J Clin Pathways. 2016;2(3):27-30.

Features

From the Field
Development and Implementation of De Novo Clinical Decision Support Rules at a Tertiary Cancer Center
Aymen Elfiky, MD, MPH, MSc; Marina Kaymakcalan, PharmD

J Clin Pathways. 2016;2(3):39-45. Received March 14, 2016; accepted March 28, 2016.

Research Report
Health Care Use and Costs Among Medicare Patients With Chronic Obstructive Pulmonary Disease Treated With Short-Acting Beta Agonists or Long-Acting Beta Agonists
Flavia Ejzykowicz, PhD; Vamsi K Bollu, PhD, MBA; Krithika Rajagopalan, PhD; Joel W Hay, PhD

J Clin Pathways. 2016;2(3):31-38.

Back to Top